Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $505.3400 (-1.7%) ($503.8100 - $516.9700) on Wed. Dec. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.24% (three month average) | RSI | 24 | Latest Price | $505.3400(-1.7%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -4.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(42%) SPLV(36%) IVW(35%) SPY(35%) | Factors Impacting REGN price | REGN will decline at least -1.12% in a week (0% probabilities). VIXM(-21%) TBT(-7%) VXX(-6%) UUP(-6%) IGOV(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.12% (StdDev 2.24%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $538.92 | 5 Day Moving Average | $511.74(-1.25%) | 10 Day Moving Average | $513.95(-1.68%) | 20 Day Moving Average | $538.92(-6.23%) | To recent high | -17.1% | To recent low | 0% | Market Cap | $53.581b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |